Skip to main content
SpringerLink
Log in

Molecular basis of hyperparathyroidism

  • Review Articles
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Summary

Several advances have been achieved toward an improved understanding of the molecular basis of human parathyroid tumorigenesis. One oncogene involved in the development of parathyroid tumors,PRAD1/cyclin D1, has been discovered and is having a broad impact in oncology and cell-cycle biology. The general genomic locations of several novel putative parathyroid tumor suppressor genes have been identified, providing guideposts toward their specific identification. An already recognized tumor suppressor gene,RB, or a close neighbor on 13q, has been linked to the pathogenesis of parathyroid carcinomas.RET has been centrally implicated in MEN-2A, and investigators are on the verge of isolating theMEN1 gene, both of which are sure to have important basic and clinical implications relevant to parathyroid and other endocrine diseases. Although mutations in theCASR gene itself play a critical role in familial disease, they do not appear to be involved in sporadic parathyroid tumorigenesis, and investigation of genes important for its regulation is warranted. Finally, new molecular genetic approaches will eventually permit the identification of additional parathyroid tumor-provoking genes and will begin to shed light upon other problems in parathyroid biology, such as the relationship between abnormal parathyroid cell proliferation and an altered setpoint in the mechanism linking extracellular calcium concentration to PTH secretion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Black WC III, Utley JR (1968) The differential diagnosis of parathyroid adenoma and chief cell hyperplasia. Am J Clin Pathol 49:761–775

    PubMed  Google Scholar 

  2. Castleman B, Roth SI (1978) Tumors of the parathyroid glands. In: Hartman WH (ed) Atlas of tumor pathology, 2nd ser, fasc 14. Armed Forces Institute of Pathology, Washington, DC

    Google Scholar 

  3. Shane E (1994) Parathyroid carcinoma. In: Bilezikian JP, Marcus R, Levine MA (eds) The parathyroids. Raven, New York, pp 575–581

    Google Scholar 

  4. Yoshimoto K, Yamasaki R, Sakai H, Tezuka V, Takahashi M, Iizuka M, Sekiya H, Saito S (1989) Ectopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemia. J Clin Endocrinol Metab 68:976–981

    Article  PubMed  CAS  Google Scholar 

  5. Nussbaum SR, Gaz RD, Arnold A (1990) Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone. N Engl J Med 323:1324–1328

    Article  PubMed  CAS  Google Scholar 

  6. Galbraith SC, Quarles LD (1994) Tertiary hyperparathyroidism and refractory secondary hyperparathyroidism. In: Bilezikian JP, Marcus R, Levine MA (eds) The parathyroids. Raven, New York, pp 159–163

    Google Scholar 

  7. Fialkow PJ, Jackson CE, Block MA, Greenwald KA (1977) Multicellular origin of parathyroid adenomas. N Engl J Med 277:696–698

    Article  Google Scholar 

  8. Jackson CE, Cerny JC, Block MA, Fialkow PJ (1982) Probable clonal origin of aldosteronomas versus multicellular origins of parathyroid adenomas. Surgery 875:875–879

    Google Scholar 

  9. Arnold A, Staunton CE, Kim HG, Gaz RD, Kronenberg HM (1988) Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 318:658–662

    Article  PubMed  CAS  Google Scholar 

  10. Cryns VL, Thor A, Xu H-J, Hu S-X, Wierman ME, Vickery AL, Benedict WF, Arnold A (1994) Loss of the retinoblastoma tumor gene in parathyroid carcinoma. N Engl J Med 330:757–761

    Article  PubMed  CAS  Google Scholar 

  11. Bystrom C, Larsson C, Blomberg C, Sandelin K, Falkmer U, Skogseid B, Oberg K, Werner S, Nordenskjold M (1990) Localization of the MEN 1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 87:1968–1972

    Article  PubMed  CAS  Google Scholar 

  12. Friedman E, Sakaguchi K, Bale AE, Falchetti A, Streeten E, Zimering MB, Weinstein LS, McBride WO, Nakamura Y, Brandi ML, Norton JA, Aurbach GD, Spiegel AM, Marx SJ (1989) Clonality of parathyroid tumors in familial multiple endocrine neoplasia type I. N Engl J Med 321:213–218

    Article  PubMed  CAS  Google Scholar 

  13. Thakker RV, Bouloux P, Wooding C, Chotal K, Broad PM, Spurr NK, Besser GM, O'Riordan JLH (1989) Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 321:218–224

    Article  PubMed  CAS  Google Scholar 

  14. Arnold A, Brown M, Urena P, Gaz RD, Sarfati E, Drueke T (1995) Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 95:2047–2053

    PubMed  CAS  Google Scholar 

  15. Falchetti A, Bale AE, Amorosi A, Bordi C, Cicchi P, Bandini S, Marx SJ, Brandi ML (1993) Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 76:139–144

    Article  PubMed  CAS  Google Scholar 

  16. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A (1991) A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350:512–515

    Article  PubMed  CAS  Google Scholar 

  17. Hosokawa Y, Arnold A (1996) Cyclin D1/PRAD1 as a central target in oncogenesis. J Lab Clin Med 127:246–252

    Article  PubMed  CAS  Google Scholar 

  18. Hsi E, Zukerberg LR, Yang WI, Arnold A (1996) Cyclin D1(PRAD1) expression in parathyroid adenomas: an immuno-histochemical study. J Clin Endocrinol Metab 81:1736–1739

    Article  PubMed  CAS  Google Scholar 

  19. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753–756

    Article  PubMed  CAS  Google Scholar 

  20. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavitgian SV, Stockert E, Day RS, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436–440

    PubMed  CAS  Google Scholar 

  21. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y (1994) Frequent somatic mutation of the MTS1/CDK41 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54:3396–3397

    PubMed  CAS  Google Scholar 

  22. Tahara H, Smith AP, Gaz RD, Arnold A (1996) Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. J Clin Endocrinol Metab 81:3663–3667

    Article  PubMed  CAS  Google Scholar 

  23. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85–87

    Article  PubMed  CAS  Google Scholar 

  24. Friedman E, De Marco L, Gejman PV, Norton JA, Bale AE, Aurbach GD, Spiegel AM, Marx SJ (1992) Allelic loss from chromosome 11 in parathyroid tumors. Cancer Res 52:6804–6809

    PubMed  CAS  Google Scholar 

  25. Radford DM, Ashley SW, Wells SA Jr, Gerhard DS (1990) Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1. Cancer Res 50:6529–6533

    PubMed  CAS  Google Scholar 

  26. Tahara H, Smith AP, Gaz RD, Cryns VL, Arnold A (1996) Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res 56:599–605

    PubMed  CAS  Google Scholar 

  27. Cryns VL, Yi SM, Tahara H, Gaz RD, Arnold A (1995) Frequent loss of chromosome arm 1p DNA in parathyroid adenomas. Genes Chromosomes Cancer 13:9–17

    PubMed  CAS  Google Scholar 

  28. Khosla S, Patel VM, Hay ID, Schaid DJ, Grant CS, van Heerden JA, Thibodeau SN (1991) Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J Clin Invest 87:1691–1699

    PubMed  CAS  Google Scholar 

  29. Mathew CGP, Smith BA, Thorpe K, Wong Z, Royle NJ, Jeffreys AJ, Ponder BAJ (1987) Deletion of genes on chromosome 1 in endocrine neoplasia. Nature 328:524–526

    Article  PubMed  CAS  Google Scholar 

  30. Moley JF, Brother MB, Fong CT, White PS, Baylin SB, Nelkin B, Wells SA, Brodeur GM (1992) Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes. Cancer Res 52:770–774

    PubMed  CAS  Google Scholar 

  31. Mulligan LM, Gardner E, Smith BA, Mathew CGP, Ponder BAJ (1993) Genetic events in tumor initiation and progression in multiple endocrine neoplasia type 2. Genes Chromosomes Cancer 6:166–177

    PubMed  CAS  Google Scholar 

  32. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SA, Goodfellow PJ, Donis-Keller H (1993) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91:1579–1583

    Article  Google Scholar 

  33. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA (1993) Mutations in the RET protooncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851–856

    PubMed  CAS  Google Scholar 

  34. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tuuacliffe A, Ponder BAJ (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458–460

    Article  PubMed  CAS  Google Scholar 

  35. Mulligan LM, Eng C, Healey CS, Clayton D, Kwok JBJ, Gardner E, Ponder MA, Frilling A, Jackson CE, Lehnert H, Neumann HPH, Thibodeau SN, Ponder BAJ (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 6:70–74

    Article  PubMed  CAS  Google Scholar 

  36. Pausova Z, Soliman E, Amizuka N, Janicic N, Konrad EM, Arnold A, Goltzman D, Hendy GN (1996) Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 81:2711–2718

    Article  PubMed  CAS  Google Scholar 

  37. Padberg BC, Schroder S, Jochum W, Kastendieck H, Roth J, Heitz PU, Komminoth P (1995) Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland. Am J Pathol 147:1600–1607

    PubMed  CAS  Google Scholar 

  38. Law WM Jr, Heath H III (1985) Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenic studies in 21 families. Ann Intern Med 102:511–519

    PubMed  Google Scholar 

  39. Marx SJ, Attie MF, Levine MA, Speigel AM, Downs RW, Lasker RD (1981) The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 60:397–412

    Article  CAS  Google Scholar 

  40. Janicic N, Soliman E, Pausova Z, Seldin MF, Riviere M, Szpirer J, Szpirer C, Hendy GN (1995) Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3–21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16. Mamm Genome 6:798–801

    Article  PubMed  CAS  Google Scholar 

  41. Heath H III, Odelberg S, Brown D, Hill VM, Robertson M, Jackson CE, The BT, Hayward N, Larsson C, Buist N, Garrett J, Leppert M (1994) Sequence analysis of the parathyroid cell calcium receptor (CaR) gene in familial benign hypercalcemia (FBH): a multiplicity of mutations? J Bone Miner Res 9 [suppl 1]:S414

    Google Scholar 

  42. Janicic N, Pausova Z, Cole DEC, Hendy GN (1995) Insertion of an Alu sequence in the Ca-sensing receptor gene in familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT). Am J Hum Genet 56:880–886

    PubMed  CAS  Google Scholar 

  43. Pearce SHS, Trump D, Wooding C, Besser GM, Chew SL, Grant DB, Heath DA, Hughes IA, Paterson CR, Whyte MP, Thakker RV (1995) Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 96:2683–2692

    PubMed  CAS  Google Scholar 

  44. Pollak MR, Brown EM, Chou YHW, Hebert SC, Marx SJ, Steinmann B, Levi T, Seidman CE, Seidman JG (1993) Mutations in the human Ca-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75:1297–1303

    Article  PubMed  CAS  Google Scholar 

  45. Pollak MR, Chou YHW, Marx SJ, Steinmann B, Cole DEC, Brandi ML, Papapoulos SE, Menko FH, Hendy GN, Brown EM, Seidman CE, Seidman JG (1994) Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 93:1108–1112

    Article  PubMed  CAS  Google Scholar 

  46. Thompson DB, Samowitz WS, Odelberg S, Davis RK, Szabo J, Heath H III (1995) Genetic abnormalities in sporadic parathyroid adenomas: loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus. J Clin Endocrinol Metab 80:3377–3380

    Article  PubMed  CAS  Google Scholar 

  47. Cryns VL, Arnold A (1995) Frequent allelic loss of chromosome arm 3q DNA in human parathyroid carcinoma. In: Program and abstracts of the 77th annual meeting of the Endocrine Society, Washington, DC, pp 3–506

  48. Hosokawa Y, Pollak MR, Brown EM, Arnold A (1995) Mutational analysis of the extracellular Ca-sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 80:3107–3110

    Article  PubMed  CAS  Google Scholar 

  49. Kifor O, Moore FD Jr, Wang P, Goldstein M, Vassilev P, Kifor I, Hebert SC, Brown EM (1996) Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81:1598–1606

    Article  PubMed  CAS  Google Scholar 

  50. Szabo J, Heath B, Hill VM, Jackson CE, Zarbo RJ, Mallette LE, Chew SL, Besser GM, Thakker RV, Huff V, Leppert MF, Heath H III (1995) Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21–q31. Am J Hum Genet 56:944–950

    PubMed  CAS  Google Scholar 

  51. Dotzenrath C, Teh BT, Farnebo F, Cupisti K, Svensson A, Toell A, Goretzki P, Larsson C (1996) Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? J Clin Endocrinol Metab 81:3194–3196

    Article  PubMed  CAS  Google Scholar 

  52. Cryns VL, Rubio MP, Thor AD, Louis DN, Arnold A (1994) p53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab 78:1320–1324

    Article  PubMed  CAS  Google Scholar 

  53. Hakim JP, Levine MA (1994) Absence of p53 point mutations in parathyroid adenoma and carcinoma. J Clin Endocrinol Metab 78:103–106

    Article  PubMed  CAS  Google Scholar 

  54. Arnold A (1993) Genetic basis of endocrine disease. 5. Molecular genetics of parathyroid gland neoplasia. J Clin Endocrinol Metab 77:1108–1112

    Article  PubMed  CAS  Google Scholar 

  55. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi S-E, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weiseman J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burn AL, Marx SJ (1997) Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 276:404–407

    Article  PubMed  CAS  Google Scholar 

  56. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi S-E, Scarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burn AL, Marx SJ (1997) Somatic mutations of theMEN1 gene in parathyroid tumours. Nat Genet 16:375–378

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Hideki Tahara

    Present address: Second Department of Internal Medicine, Osaka City University Medical School, 1-5-7 Asahi-machi, Abeno-ku, 545, Osaka, Japan

Authors and Affiliations

  1. Laboratory of Endocrine Oncology, Massachusetts General Hospital and Harvard Medical School, 32 Fruit Street, GRJ1021, 02114, Boston, MA, USA

    Hideki Tahara & Andrew Arnold

Authors
  1. Hideki Tahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew Arnold
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Tahara, H., Arnold, A. Molecular basis of hyperparathyroidism. J Bone Miner Metab 15, 173–178 (1997). https://doi.org/10.1007/BF02491378

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02491378

Key words

Search

Navigation